Clinical and Economic Burden of Illness in Patients with Persistent or Chronic Primary Immune Thrombocytopenia Treated with TPO-Ras and RituximabDavid J. Kuter, Natalia Petruski‐Ivleva, Siddhi Umarje et al.|Blood|2023Cited by 2
Prevalence and Incidence of Primary Autoimmune Hemolytic Anemia and Cold Agglutinin Disease in the United States, 2016-2022: A Retrospective Study in Administrative ClaimsSylvie Bozzi, Natalia Petruski‐Ivleva, Siddhi Umarje et al.|Blood|2023Cited by 2
Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016–2023Sylvie Bozzi, Natalia Petruski‐Ivleva, Siddhi Umarje et al.|PLoS ONE|2025Cited by 1
EPH85 Clinical Burden of GM2 Gangliosidoses in the United States (US): A Retrospective Observational Cohort Study Using Electronic Health Records (EHR)M.B. Rodríguez, Cynthia J. Tifft, Natalia Petruski‐Ivleva et al.|Value in Health|2023Cited by 0
Clinical Burden of Illness in Patients with Persistent or Chronic Primary Immune Thrombocytopenia Treated with Advanced Therapies in the United StatesDavid J. Kuter, Natalia Petruski‐Ivleva, Imène Gouia et al.|Blood|2024Cited by 0